| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
2e-18 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
8e-15 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-14 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-14 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
5e-14 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
8e-14 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-13 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-12 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |